Kestra Advisory Services’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
IA
MCI
HNB
Kestra Advisory Services's AMED Position: Q3 2025 in Review
Kestra Advisory Services sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,488 shares — an estimated $245K sold.
Kestra Advisory Services first reported a position in AMED in Q4 2020 and held it in 10 quarters. The position peaked at $1.37M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Kestra Advisory Services reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Kestra Advisory Services sold 2,488 Amedisys shares in Q3 2025, an estimated $245K.
- Kestra Advisory Services first reported a position in Amedisys in Q4 2020 and held it in 10 quarters.
- Kestra Advisory Services's Amedisys position peaked at $1.37M in Q4 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Kestra Advisory Services's 13F filing for Q3 2025, filed 14 Nov 2025.